Home Obi Profile Fees Services News Publications Contact  
You are here: Title Details
Search  
    Login
Inventions Industrial DesignTechnological Information
DOSAGES OF IMMUNOCONJUGATES OF ANTIBODIES AND SN-38 FOR IMPROVED EFFICACY AND DECREASED TOXICITY

No-Receipt date 2022-01538 - 27/04/2022
No-Filing date 20220400915 - 27/04/2022
No-Granting date 3110236 - 06/05/2022
No-EPO application date 13861658.6 - 23/07/2013
No-EPO granting date 2900277 - 16/02/2022
Gazette No-Publication date of application -
Gazette No-Publication date of granted patent 5/2022 - 08/06/2022
Expiration date 24/07/2033
Kind of title Validation of European Patent
Legal status VALID
Priorities US201261736684 P13/12/2012/US
US201361749548 P07/01/2013/US
Active Substance of Supplementary Certificates -

IPC Classification
Ipc Class
A61K 47/68
A61P 35/00

Related Documents

Related Titles

Owners
CodeFirstnameSurnameAddressTownZIPCountry
1405714 IMMUNOMEDICS, INC. 300 AMERICAN ROADMORRIS PLAINS, NJ 07950 UNITED STATES OF AMERICA (USA)

Inventors
CodeFirstnameSurname
3621560 GOVINDAN, SERENGULAM, V.
3621561 GOLDENBERG, DAVID, M.

Representatives
CodeFirstnameSurnameAddressTownZip
3190KONSTANTINOSKILIMIRIS "PATRINOS & KILIMIRIS DIKIGORIKI ETAIRIA"CHATZIGIANNI MEXI 7ATHINA (ATTIKIS)11528

Contact
CodeFirstnameSurnameAddressTownZipCountry
8149KONSTANTINOSKILIMIRISCHATZIGIANNI MEXI 7ATHINA (ATTIKIS)11528 GREECE

Owners History

Title Instruments

Payments history 13 renewals have been done
Print
Dues Online PaymentNational Patent RegisterOne Stop Shop (OSS)
© OBI all rights reserved designed & developed by PROFILE S.A.
Certified QMS : EN ISO 9001:2015 and ΕΝ ISO 14001:2015